Lv1
30 积分 2024-01-10 加入
Global Incidence and Prevalence of Chronic Rhinosinusitis: A Systematic Review
10天前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
12天前
已完结
A novel dual targeted antibacterial agent for Helicobacter pylori
16天前
已完结
Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation
22天前
已完结
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps
1个月前
已完结
Pioneering a paradigm shift in asthma management: remission as a treatment goal
2个月前
已完结
Unified Airway Disease
2个月前
已完结
Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007–2030
3个月前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
4个月前
已完结
皖公网安备34019202002308
